首页 / 院系成果 / 成果详情页

Clinical Efficacy of Modified Yanghe Decoction in Ankylosing Spondylitis: A Randomized Controlled Trial  期刊论文  

  • 编号:
    55fdc204-1539-4184-aa1f-6e363f03087d
  • 作者:
  • 语种:
    英文
  • 期刊:
    MEDICAL SCIENCE MONITOR ISSN:1643-3750 2018 年 24 卷 (2912 - 2918) ; MAY 8
  • 收录:
  • 关键词:
  • 摘要:

    Background: This study evaluated the effects of Modified Yanghe Decoction on pain, disease activity, and functional capacity, and its safety in subjects with ankylosing spondylitis (AS).
    Material/Methods: A randomized, controlled study of subjects with AS was conducted over 8 weeks to compare the efficacy of the Modified Yanghe Decoction to celecoxib-sulfasalazine therapy. Subjects were evaluated at visit 1, and at weeks 4 and 8 of the trial. The Bath ankylosing spondylitis disease activity index (BASDAI), nocturnal back pain (NBP), total back pain (TBP), patient global disease activity (PGDA), the Bath ankylosing spondylitis functional index (BASH), and the Bath ankylosing spondylitis metrology index (BASMI) were measured at each time point. Safety was monitored throughout the study through blood, urine, and stool samples, along with heart, liver, and kidney function tests. The ASAS 20 improvement criteria were used as efficacy criteria.
    Results: A total of 80 subjects were included. Both treatment groups were effective: 32 subjects (80%) in the Modified Yanghe Decoction group and 34 (85%) in celecoxib-sulfasalazine group met ASAS 20 improvement criteria; no statistically significant difference between groups was observed (P>0.05). Two subjects in the Modified Yanghe Decoction group reported mild diarrhea during the trial. In the celecoxib-sulfasalazine group, 8 subjects experienced upper-abdominal pain; in 3 subjects this was combined with lowered white blood cell count and in 1 subject it was combined with mild proteinuria. This represents a statistically significant difference in safety (P<0.05) between the 2 treatments.
    Conclusions: This study demonstrates the efficacy and safety of the Modified Yanghe Decoction in AS treatment, especially for patients who have poor clinical responses, severe adverse reactions, or for patients unable to afford the standard clinical options.

  • 推荐引用方式
    GB/T 7714:
    Wang Yiquan,Xiao Xiaoli, et al. Clinical Efficacy of Modified Yanghe Decoction in Ankylosing Spondylitis: A Randomized Controlled Trial [J].MEDICAL SCIENCE MONITOR,2018,24:2912-2918.
  • APA:
    Wang Yiquan,Xiao Xiaoli.(2018).Clinical Efficacy of Modified Yanghe Decoction in Ankylosing Spondylitis: A Randomized Controlled Trial .MEDICAL SCIENCE MONITOR,24:2912-2918.
  • MLA:
    Wang Yiquan, et al. "Clinical Efficacy of Modified Yanghe Decoction in Ankylosing Spondylitis: A Randomized Controlled Trial" .MEDICAL SCIENCE MONITOR 24(2018):2912-2918.
  • 条目包含文件:
    文件类型:PDF,文件大小:
    正在加载全文
浏览次数:4 下载次数:0
浏览次数:4
下载次数:0
打印次数:0
浏览器支持: Google Chrome   火狐   360浏览器极速模式(8.0+极速模式) 
返回顶部